European Psychiatry (Mar 2023)

quality of remission in the major depressive disorder

  • H. Chebli,
  • H. berrada,
  • M. chtibi,
  • S. belbachir,
  • A. ouanass

DOI
https://doi.org/10.1192/j.eurpsy.2023.1762
Journal volume & issue
Vol. 66
pp. S832 – S832

Abstract

Read online

Introduction Depression is second only to cardiovascular disease as a cause of disability and affects 3 to 5% of the general population. The therapist always tries to guarantee a total remission of the symptoms of depression, but partial remission remains frequent. Objectives Evaluating the quality of remission in a group of patients followed for major depressive disorder at the Arrazi Hospital in Salé. Methods Cross-sectional study in adult patients followed up in consultation for major depressive disorder according to DSM-V criteria and having been under treatment for at least 2 months. Information was collected using a hetero questionnaire containing information on sociodemographic data and the depressive episode. The quality of remission is assessed using the Hamilton Rating Scale for Depression. Results We recruited 70 patients followed for major depressive disorder at 2 months of evolution. The Hamilton scale revealed that 40% of patients were in partial remission. Conclusions Residual symptoms can be the cause of relapse in major depressive disorder, hence the interest in seeking both a symptomatic remission and a complete functional remission, and this by the evaluation and the continuous management of the patients. Disclosure of Interest None Declared